JP2023516685A5 - - Google Patents
Info
- Publication number
- JP2023516685A5 JP2023516685A5 JP2022552807A JP2022552807A JP2023516685A5 JP 2023516685 A5 JP2023516685 A5 JP 2023516685A5 JP 2022552807 A JP2022552807 A JP 2022552807A JP 2022552807 A JP2022552807 A JP 2022552807A JP 2023516685 A5 JP2023516685 A5 JP 2023516685A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- viral vector
- vector according
- promoter
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062984716P | 2020-03-03 | 2020-03-03 | |
| US62/984,716 | 2020-03-03 | ||
| PCT/US2021/020721 WO2021178571A1 (en) | 2020-03-03 | 2021-03-03 | On demand expression of exogenous factors in lymphocytes to treat hiv |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516685A JP2023516685A (ja) | 2023-04-20 |
| JP2023516685A5 true JP2023516685A5 (https=) | 2024-03-04 |
Family
ID=77614437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552807A Pending JP2023516685A (ja) | 2020-03-03 | 2021-03-03 | Ｈｉｖを処置するためのリンパ球における外因性因子のオンデマンド発現 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240279678A1 (https=) |
| EP (1) | EP4114439A4 (https=) |
| JP (1) | JP2023516685A (https=) |
| KR (1) | KR20220150320A (https=) |
| CN (1) | CN115551532A (https=) |
| AU (1) | AU2021232603A1 (https=) |
| BR (1) | BR112022017678A2 (https=) |
| CA (1) | CA3170630A1 (https=) |
| IL (1) | IL296096A (https=) |
| WO (1) | WO2021178571A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116064678A (zh) | 2016-01-15 | 2023-05-05 | 美国基因技术国际有限公司 | 用于活化γ-δT细胞的方法和组合物 |
| WO2017156311A2 (en) | 2016-03-09 | 2017-09-14 | American Gene Technologies International Inc. | Combination vectors and methods for treating cancer |
| JP2020524996A (ja) | 2017-06-16 | 2020-08-27 | アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド | ヒトガンマデルタｔ細胞を介する腫瘍細胞傷害性の活性化のための方法および組成物 |
| US11352646B2 (en) | 2018-11-05 | 2022-06-07 | American Gene Technologies International Inc. | Vector system for expressing regulatory RNA |
| JP2023525969A (ja) * | 2020-05-19 | 2023-06-20 | イグザカ フランス | インビトロおよびインビボでのｃｄ３＋細胞における遺伝子治療産物の発現のためのプロモータ配列 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998011244A2 (en) * | 1996-09-11 | 1998-03-19 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Aav4 vector and uses thereof |
| WO2003040311A2 (en) * | 2001-10-25 | 2003-05-15 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services | Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4 |
| AU2003301556A1 (en) * | 2002-05-07 | 2004-05-13 | Chiron Corporation | Hiv envelope-cd4 complexes and hybrids |
| WO2015012924A2 (en) * | 2013-04-29 | 2015-01-29 | The Trustees Of The University Of Pennsylvania | Tissue preferential codon modified expression cassettes, vectors containing same, and use thereof |
| MX2018003463A (es) * | 2015-09-22 | 2018-09-06 | Univ Pennsylvania | Método de redireccionamiento de células t para tratar la infección por virus de inmunodeficiencia humana (vih). |
| EP3468617A4 (en) * | 2016-06-08 | 2020-01-22 | American Gene Technologies International Inc. | SYSTEM FOR THE NON-INTEGRAL VIRAL ISSUE AND PROCEDURE RELATING TO IT |
| AU2017292582C1 (en) * | 2016-07-08 | 2021-11-11 | American Gene Technologies International Inc. | HIV pre-immunization and immunotherapy |
| JP7260170B2 (ja) * | 2017-01-09 | 2023-04-18 | アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド | 事前の免疫化ステップのないｈｉｖ免疫療法 |
| JP2020524996A (ja) * | 2017-06-16 | 2020-08-27 | アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド | ヒトガンマデルタｔ細胞を介する腫瘍細胞傷害性の活性化のための方法および組成物 |
| KR20200135852A (ko) * | 2018-03-27 | 2020-12-03 | 아메리칸 진 테크놀로지스 인터내셔널 인코포레이티드 | 유전자 변형 림프구의 제조 방법 |
| AU2019302603A1 (en) * | 2018-07-13 | 2021-01-14 | Nanjing Legend Biotech Co., Ltd. | Co-receptor systems for treating infectious diseases |
-
2021
- 2021-03-03 WO PCT/US2021/020721 patent/WO2021178571A1/en not_active Ceased
- 2021-03-03 BR BR112022017678A patent/BR112022017678A2/pt unknown
- 2021-03-03 IL IL296096A patent/IL296096A/en unknown
- 2021-03-03 CA CA3170630A patent/CA3170630A1/en active Pending
- 2021-03-03 JP JP2022552807A patent/JP2023516685A/ja active Pending
- 2021-03-03 KR KR1020227033216A patent/KR20220150320A/ko active Pending
- 2021-03-03 US US17/908,509 patent/US20240279678A1/en active Pending
- 2021-03-03 AU AU2021232603A patent/AU2021232603A1/en active Pending
- 2021-03-03 CN CN202180032693.0A patent/CN115551532A/zh active Pending
- 2021-03-03 EP EP21764102.6A patent/EP4114439A4/en active Pending
-
2023
- 2023-07-28 US US18/227,775 patent/US20240141374A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023516685A5 (https=) | ||
| US11612649B2 (en) | HIV pre-immunization and immunotherapy | |
| Bunnell et al. | Gene therapy for infectious diseases | |
| US20250121050A1 (en) | Methods of producing cells resistant to hiv infection | |
| CN110462029B (zh) | 无预先免疫步骤的hiv免疫疗法 | |
| JP2019527055A5 (https=) | ||
| US20240115604A1 (en) | Methods of manufacturing genetically-modified lymphocytes | |
| US20240141374A1 (en) | On demand expression of exogenous factors in lymphocytes | |
| von Gegerfelt et al. | Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization | |
| Buffa et al. | A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1) HXB2 Rev/Env or codon-optimized HIV-1JR-FL gp120 generates durable immune responses in mice | |
| Lori et al. | Gene therapy approaches to HIV infection | |
| RU2697781C2 (ru) | Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека | |
| Moriya et al. | Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences | |
| Warner et al. | Human immunodeficiency virus immunotherapy using a retroviral vector | |
| WO2025064901A2 (en) | Hiv vaccination and immunotherapy | |
| Fujii et al. | A potential live vector, foamy virus, directed intra-cellular expression of ovine interferon-τ exhibited the resistance to HIV infection | |
| WO2025050047A1 (en) | Combination immunotherapy and antiviral treatment |